Living Donor Liver Transplantation for Congenital Portosystemic Shunt Presenting With Hyperinsulinemic Hypoglycemia

Masashi Kadohisa,Tatsuya Okamoto,Kougorou Iwanaga,Miki Yamamoto,Elena Yukie Uebayashi,Eri Ogawa,Hideaki Okajima,Etsuro Hatano
DOI: https://doi.org/10.1111/petr.14871
2024-10-08
Pediatric Transplantation
Abstract:Background A congenital portosystemic shunt (CPSS) is defined as abnormal vascular communications between the portal vein and the systemic vein. Encephalopathy, hepatopulmonary syndrome, and portopulmonary hypertension are manifestations in patients with CPSS. Hyperinsulinemic hypoglycemia is also one of the manifestations of CPSS. Hyperinsulinemic hypoglycemia secondary to CPSS is caused by a lack of hepatic first‐pass elimination of insulin, which is secreted from pancreatic beta cells. Case Presentation A 7‐month‐old boy had hypergalactosemia detected by newborn mass screening. Enhanced abdominal computed tomography showed the absence of the portal vein trunk and extrahepatic portosystemic communication between the superior mesenteric vein and the inferior vena cava. He had suffered from uncontrollable hyperinsulinemic hypoglycemia under protein and lactose restriction. We performed living donor liver transplantation (LDLT) using a left lateral segment graft from his father. The postoperative course was uneventful and the hypoglycemic attacks disappeared. Conclusion We believe that uncontrolled hyperinsulinemic hypoglycemia secondary to CPSS is an indication of LDLT.
pediatrics,transplantation
What problem does this paper attempt to address?